Cargando…
Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
AIM: This retrospective cohort study evaluated whether metformin use in patients with type 2 diabetes mellitus might reduce the risk of biliary tract cancer (BTC); and explored whether metformin use might affect the overall survival in patients who developed BTC. METHODS: New-onset type 2 diabetes p...
Autor principal: | Tseng, Chin-Hsiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653020/ https://www.ncbi.nlm.nih.gov/pubmed/33194743 http://dx.doi.org/10.3389/fonc.2020.587666 |
Ejemplares similares
-
Metformin and lung cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2017) -
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
por: Chin-Hsiao, Tseng
Publicado: (2019) -
Metformin Reduces Thyroid Cancer Risk in Taiwanese Patients with Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2014) -
Metformin may reduce oral cancer risk in patients with type 2 diabetes
por: Tseng, Chin-Hsiao
Publicado: (2015) -
Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
por: Tseng, Chin-Hsiao
Publicado: (2016)